Priority targets

Recent progress in computational design and structural analysis allows reverse engineering of biologically active antigens from broadly neutralizing antibodies.

Pediatric Vaccines
- Respiratory syncytial virus (RSV)
- Metapneumovirus (MPV)
- Parainfluenza viruses (PIV)

Universal Influenza Vaccines
- Influenza type A subtypes H1 and H3
- Influenza type B Victoria and Yamagata lineages